Back

Shifting From an Expected to an Opportunistic Pathogen: Characteristics and Trends of Infant Late and Very Late Onset Group B streptococcal (GBS) infection in a Canadian city over a 27-year period

Robinson, J. L.; Suresh, S.; Kumar, M.; Isah, I.; Tyrrell, G.

2025-11-06 infectious diseases
10.1101/2025.11.03.25339435 medRxiv
Show abstract

BackgroundDespite decades of study, the characteristics of infants with invasive group B streptococcus (GBS) late onset disease (LOD) (onset day 7 to 89 of life) and in particular very late onset disease (VLOD) (after day 89 of life) are not well described. Materials and MethodsThis was a retrospective cohort study of infants hospitalized in four Edmonton hospitals April 1, 1994 through June 30, 2022 with LOD or VLOD GBS invasive disease. Data were collected on demographics, date of onset of GBS infection, clinical manifestations and outcomes. ResultsThere were 115 episodes of LOD in 111 infants of which 49 (45%) were preterm. Onset was on median day 27 (IQR 19-40.5) of life. All but one infant was bacteremic while 38 (34%) had proven and 17 (15%) had possible GBS meningitis. Five (5%) died before hospital discharge with all deaths presumed to be due to GBS. There were 11 episodes of VLOD in 11 infants (7 [64%] preterm) presenting on median day 116 (IQR 103-138) (range 93-207) of life. Three (27%) had GBS meningitis. All survived to discharge. Infants with VLOD were less likely to be born vaginally and more likely to be mechanically ventilated during their birth hospitalization and have invasive disease with other pathogens than were infants with LOD. Serotype III accounted for 78% of LOD and 64% of VLOD cases. ConclusionGBS remains a significant cause of infant morbidity and mortality. There is increasing evidence that GBS may sometimes be an opportunistic pathogen in infants over 90 days of age.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 15%
12.4%
2
Pediatric Infectious Disease Journal
17 papers in training set
Top 0.1%
6.7%
3
Antimicrobial Resistance & Infection Control
11 papers in training set
Top 0.1%
6.2%
4
Journal of the Pediatric Infectious Diseases Society
10 papers in training set
Top 0.1%
4.8%
5
Clinical Infectious Diseases
235 papers in training set
Top 0.6%
4.3%
6
The Journal of Infectious Diseases
202 papers in training set
Top 0.9%
4.0%
7
Open Forum Infectious Diseases
142 papers in training set
Top 0.6%
4.0%
8
Journal of Antimicrobial Chemotherapy
46 papers in training set
Top 0.3%
4.0%
9
Journal of Medical Microbiology
25 papers in training set
Top 0.1%
3.2%
10
Eurosurveillance
83 papers in training set
Top 0.2%
3.2%
50% of probability mass above
11
Journal of Infection
78 papers in training set
Top 0.3%
3.2%
12
Microbiology Spectrum
469 papers in training set
Top 5%
2.8%
13
Scientific Reports
3612 papers in training set
Top 47%
2.1%
14
BMC Infectious Diseases
133 papers in training set
Top 2%
2.1%
15
The Journal of Pediatrics
16 papers in training set
Top 0.2%
1.9%
16
Infection Control & Hospital Epidemiology
17 papers in training set
Top 0.1%
1.4%
17
The Lancet Infectious Diseases
73 papers in training set
Top 1.0%
1.1%
18
International Journal of Infectious Diseases
129 papers in training set
Top 2%
1.1%
19
European Journal of Clinical Microbiology & Infectious Diseases
15 papers in training set
Top 0.1%
1.1%
20
BMJ Open
601 papers in training set
Top 11%
1.1%
21
Emerging Infectious Diseases
105 papers in training set
Top 1%
1.1%
22
PLOS Neglected Tropical Diseases
466 papers in training set
Top 5%
1.1%
23
Vaccine
203 papers in training set
Top 1%
1.1%
24
PLOS Global Public Health
344 papers in training set
Top 7%
1.1%
25
Nature Communications
5641 papers in training set
Top 54%
1.0%
26
Journal of Clinical Virology
63 papers in training set
Top 0.8%
0.8%
27
Microbial Genomics
225 papers in training set
Top 2%
0.8%
28
mBio
833 papers in training set
Top 12%
0.6%
29
mSphere
302 papers in training set
Top 8%
0.6%
30
JAMA Network Open
130 papers in training set
Top 4%
0.6%